San Diego, CA, United States of America

Tong Zhu

USPTO Granted Patents = 29 

 

 

Average Co-Inventor Count = 5.7

ph-index = 10

Forward Citations = 211(Granted Patents)


Location History:

  • Johnston, IA (US) (2003 - 2005)
  • Chapel Hill, NC (US) (2005 - 2010)
  • Durham, NC (US) (2009 - 2012)
  • Research Triangle Park, NC (US) (2009 - 2013)
  • San Diego, CA (US) (2006 - 2024)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
29 patents (USPTO):

Title: Innovations in Drug-Conjugates: The Contributions of Tong Zhu

Introduction: Tong Zhu is a prominent inventor based in San Diego, CA, who has made significant strides in the field of drug conjugates. With an impressive portfolio of 28 patents, Zhu's contributions to pharmaceutical science have paved the way for advanced treatment options.

Latest Patents: One of Zhu's latest patents involves drug-conjugates, conjugation methods, and their uses. This patent describes an active agent-conjugate along with methods for its preparation and various applications. Another notable patent focuses on drug-conjugates with a targeting molecule and two distinct drugs, showcasing an improved antibody-drug conjugate (ADC) composition. This innovative design involves attaching a first drug conjugate to a dual cysteine residue on a targeting protein, while a second drug conjugate with a different payload is attached to a lysine residue, enhancing the therapeutic efficacy of the treatment.

Career Highlights: Throughout his career, Tong Zhu has collaborated with leading companies in the pharmaceutical industry, such as Syngenta Participations AG and Sorrento Therapeutics, Inc. His work has significantly influenced the development of targeted therapies and drug delivery systems.

Collaborations: Zhu has worked alongside esteemed colleagues, including Zhenwei Miao and Yufeng Hong. Together, they have driven forward research and innovation in drug conjugate technologies.

Conclusion: Tong Zhu's contributions in the realm of drug-conjugates have established him as a leading figure in pharmaceutical innovation. With a robust patent portfolio and a track record of collaboration, Zhu continues to impact the future of targeted drug therapies significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…